Journal article
Impact of intensity of conditioning therapy in patients aged 40–60 years with AML/myelodysplastic syndrome undergoing allogeneic transplantation
Abstract
The optimum intensity of conditioning therapy in patients aged 40–60 years with AML and myelodysplastic syndrome (MDS) undergoing allogeneic haematopoietic cell transplantation (alloHCT) remains uncertain. We compared outcomes of reduced intensity conditioning (RIC) and conventional intensity conditioning (CIC) in 101consecutive patients (CIC, 62; RIC, 39) with AML and MDS aged 40–60 years undergoing alloHCT from 2002 to 2008 at our centre. The …
Authors
Khabori MA; El-Emary M; Xu W; Guyatt G; Galal A; Kuruvilla J; Lipton J; Messner H; Gupta V
Journal
Bone Marrow Transplantation, Vol. 46, No. 4, pp. 516–522
Publisher
Springer Nature
Publication Date
April 2011
DOI
10.1038/bmt.2010.164
ISSN
0268-3369